Osteoporosis International

Article	Citations
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	894
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	390
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	123
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	120
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	107
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	87
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	86
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	69
One versus 2 years of alendronate following denosumab: the CARD extension	62
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	61
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	57
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	57
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	57
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches	53
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	53
Postmenopausal osteoporosis and the global burden of fractures: a gynecologist’s perspective	49
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	48
Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement	48
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	47
Return on investment of fracture liaison services: a systematic review and analysis	44
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	43
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	41
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	39
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis	38
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	38

Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	38
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	38
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	37
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	37
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	34
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS	32
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	32
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	31
Artificial intelligence insights into osteoporosis: comment	31
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	30
Advantages of measuring hand grip strength in osteoporosis patients	29
Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)	29
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	28
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family	28
International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures	28
Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study	28
Projected burden of femoral fracture surgeries in Japan through 2035: a nationwide population-based modeling study	27
Romosozumab and antiresorptive treatment: the importance of treatment sequence	27
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up	27
Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	27
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year	27
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	27
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	27
Correction to: Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	26
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study	26
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	25
Zoledronic acid–induced severe lymphopenia	25
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series	25
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study	24
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis	24
Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care	24
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	23
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients re	23
The importance of structural barriers of osteoporotic hip fracture in the elderly	23
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	23
The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography	22
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density	22
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study	22
Trends of incidence and 1-year mortality of vertebral fractures in Korea	22
Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis	22
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study	22
Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA	22
The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis	22
Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review	22
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	22
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis	21
Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010–2021	21
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population	21
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	21
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review	21

Bridging the knowledge gap in rare bone disorders: insights from the APCO Asia-Pacific Rare Bone Disorders Engagement (ASPIRE) survey	21
Effects of microplastics on the bones: a comprehensive review	21
Fracture risk following bariatric surgery: a systematic review and meta-analysis	20
Authors’ response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings	20
Opportunistic osteoporosis screening using chest CT with artificial intelligence	20
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review	20
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	20
Insulin resistance, bone health, and fracture risk	20
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-an	20
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study	20
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.	19
Development and validation of a prediction model for falls among older people using community-based data	19
Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	19
Author response to OSIN-D-24–00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	19
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	19
Letter of rebuttal to ‘Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications—a systematic review’	19
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany	18
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analy	18
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty	18
Comment on “Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018”	18
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment	18
Error in Mendelian randomization analysis in “Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma”	18
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity	18
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study	18
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective	17
Mortality among older adults with osteoporotic vertebral fracture	17
Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and meta‑analysis	17
Anabolic-first therapy and planned sequential care in very-high-risk fracture patients: leveraging the REFRA FLS-SEIOMM signal for global implementation	17
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis	17
The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery	17
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study	17
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank	16
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study	16
Prevalence of low bone mineral density (T-score ≤  − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis	16
Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women	16
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients	16
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study	16
Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review	16
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment	16
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients	16
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis	16
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk	16
Editorial: Is REMS-BMD Truly a Measured Parameter? A Call for Transparency and Technical Clarification	16
A tribute to Uri A. Liberman, 1935–2022	16
Author Response to OSIN-D-24–00437: Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	16
Letter to the editor concerning “Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis”	15
Fragility fracture and fear of falling in middle aged adults-a prevalence study	15
Prediabetes and insulin resistance are associated with lower trabecular bone score (TBS): cross-sectional results from the Study of Women’s Health Across the Nation TBS Study	15
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening	15
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture	15
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)	15
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)	15
The hip fracture incidence in the high-risk area Oslo continues to decline	15
Prolonged hypercalcemia induced by teriparatide: a case report and literature review	15
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among o	15
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis	15
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study	15
Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis	15
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?	15
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study	14
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41	14
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women’s Health Across the Nation (SWAN)	14
Birth weight and birth length affect future fracture risk differently in men and women	14
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis	14
The high-risk hip fracture patient and the palliative care consult	14
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults	14
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study	14
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group	14
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review	14
Prognosis and institutionalization of frail community-dwelling older patients following a proximal femoral fracture: a multicenter retrospective cohort study	14
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case–control study	14
Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study	14
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthrit	14
Atypical periprosthetic femoral fracture with stem breakage: a case report	13
Focal dermal hypoplasia: a probable underrecognized low bone mass disorder secondary to aberrant Wnt signaling	13
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab	13
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis	13
Femur geometry influences atypical femoral fracture location	13
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus	13
An invited rebuttal letter. Author response to: OSIN-D-25-02044: Critical considerations on the article by Bobelyak et al. (2025) “Bone mineral density assessment using radiofrequency echographic mult	13

The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-D	13
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population	13
Author response to: OSIN-D-24–00381, artificial intelligence insights into osteoporosis	13
Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement	13
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis	13
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report	13
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials	12
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis	12
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports	12
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis	12
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis	12
Incidence of hip fractures in Mexico 2006–2019: increasing numbers but decreasing rates	12
Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study	12
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose	12
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials	12
Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling	12
Secular trend of humeral fractures incidence rates in patients ≥ 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013	11
Physical function and physical activity in adults with X-linked hypophosphatemia	11
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event	11
Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study	11
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study	11
Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis	11
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	11
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	11
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	11
Performance of FRAX in older adults with frailty: the Framingham Heart Study	11
The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit	11
Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia	11
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	11
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	11
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	11
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	11
Appropriate dosing of burosumab in tumor-induced osteomalacia	11
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial	11
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis	11
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture	11
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	11
Discontinuation of denosumab in men with prostate cancer	11
Gender differences in osteoporosis	10
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	10
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	10
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	10
IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts	10
Association between total and animal proteins with risk of fracture: A systematic review and dose–response meta-analysis of cohort studies	10
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	10
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	10
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	10
Management of osteoporosis in patients with chronic kidney disease	10
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment	10
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	10
Author response to: OSIN-D-25–00317, “Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population”	10
Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service	10
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis	10
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	10
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	10
Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography	10
IOF position on scientists and societies operating in conflict zones	10
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	10
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	10
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study	10
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	10
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	9
Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis	9
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX	9
The clinician’s guide to prevention and treatment of osteoporosis	9
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy:	9
Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review	9
Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals	9
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	9
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	9
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures	9
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM	9
Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up”	9
A systematic review and meta-analysis of sequential treatment strategies for osteoporosis	9
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	9
Pharmacist interventions in osteoporosis management: a systematic review	9
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-labe	9
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models — data from the Belgian FRISBEE cohort	9
Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?	9
Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males	9
Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data	8
Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography	8
Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability	8
Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018	8
Response to Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery	8
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	8
Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study	8
Primary hyperparathyroidism and fracture probability	8
The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans—a histomorphometry centered scoping review	8
Letters to the Editor for “Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study”	8
Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders	8
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	8
Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan	8
Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021—reversal of the secular trend?	8
The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review	8